Samsara BioCapital’s KALA BIO KALA Stock Holding History

Samsara BioCapital’s Portfolio KALA Stock Details KALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-240	Closed	-$181K	–	52
2023 Q1	$181K	Hold	240	–	–	0.04%	50
2022 Q4	$459K	Hold	240	–	–	0.1%	43
2022 Q3	$132K	Sell	240 -1	-0.4%	-$785	0.03%	54
2022 Q2	$180K	Hold	241	–	–	0.05%	53
2022 Q1	$830K	Hold	241	–	–	0.21%	49
2021 Q4	$727K	Hold	241	–	–	0.14%	48
2021 Q3	$1.57M	Hold	241	–	–	0.25%	42
2021 Q2	$3.19M	Hold	241	–	–	0.39%	36
2021 Q1	$4.05M	Hold	241	–	–	0.75%	31
2020 Q4	$4.08M	Buy	241 +60	+33%	+$1.13M	0.41%	24
2020 Q3	$3.38M	Buy	181 +45	+33%	+$1.03M	0.94%	21
2020 Q2	$3.56M	Buy	136 +110	+423%	+$3.12M	1.15%	21
2020 Q1	$563K	Buy	+26	New	+$415K	0.32%	28

Other funds holding KALA

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

KOCAA

Knights of Columbus Asset Advisors New Haven, Connecticut $2B AUM 42.86% 1-Year Est. Return

Samsara BioCapital's KALA Position: Q2 2023 in Review

Samsara BioCapital sold out of KALA BIO (KALA) in Q2 2023, closing a stake of 240 shares — an estimated $181K sold.

Samsara BioCapital first reported a position in KALA in Q1 2020 and held it in 13 quarters. The position peaked at $4.08M in Q4 2020. 24 funds tracked by Wall St. Rank hold KALA as of Q2 2023.

Samsara BioCapital reported no remaining KALA BIO position as of Q2 2023 after selling out during the quarter.
Samsara BioCapital sold 240 KALA BIO shares in Q2 2023, an estimated $181K.
Samsara BioCapital first reported a position in KALA BIO in Q1 2020 and held it in 13 quarters.
Samsara BioCapital's KALA BIO position peaked at $4.08M in Q4 2020.
24 funds tracked by Wall St. Rank held KALA BIO as of Q2 2023.

Based on Samsara BioCapital's 13F filing for Q2 2023, filed 14 Aug 2023.